OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.

The JOURNAL OF ORTHOPAEDIC RESEARCH, published by WILEY, stands as a premier peer-reviewed journal in the field of orthopedics and sports medicine, showcasing high-impact research with a notable impact factor and categorized in the top Q1 quartile for 2023. Since its inception in 1983, this journal has continuously evolved to meet the needs of a dynamic scientific community, serving as a vital resource for researchers, clinicians, and students engaged in the study and practice of orthopedics. With commendable rankings, positioned at Rank #47 out of 321 in the Medicine Orthopedics and Sports Medicine category, and boasting a remarkable 85th percentile in Scopus rankings, it highlights groundbreaking studies and advances in orthopedic science. While not an open-access journal, it provides diverse access options to ensure that its contributions are available to a broad academic audience. The journal plays a crucial role in disseminating innovative ideas and fostering collaboration within the orthopedic research community, thereby promoting improved patient care and outcomes in musculoskeletal health.

Current Osteoporosis Reports, published by Springer, is a premier journal dedicated to advancing the understanding of osteoporosis and related metabolic bone diseases. With its ISSN 1544-1873 and E-ISSN 1544-2241, this esteemed publication has established itself as a vital resource in the field of endocrinology, diabetes, and metabolism, evidenced by its Q1 ranking and 82nd percentile in Scopus. Spanning from 2003 to 2024, the journal seeks to disseminate high-quality research, critical reviews, and comprehensive reports that address the complexities of osteoporosis, offering insights into diagnosis, treatment, and prevention strategies. Although not an open-access journal, Current Osteoporosis Reports ensures that researchers, healthcare professionals, and students have access to cutting-edge scientific knowledge that fuels innovative approaches to improving patient care and outcomes. The journal's impact in shaping the dialogue and research landscape in its domain underscores its importance for anyone invested in improving bone health.

Journal of Clinical and Translational Endocrinology is a peer-reviewed open access journal published by Elsevier that has been serving the endocrinology community since its inception in 2014. With an ISSN of 2214-6237, this journal focuses on the critical intersection of clinical and translational research in endocrinology, diabetes, and metabolism, offering insights that bridge laboratory discoveries with patient care. It holds a commendable position in the field, ranking Q3 for Endocrinology and Q2 for Endocrinology, Diabetes, and Metabolism, reflecting its rigorous standards and relevance to contemporary research. Situated in the Netherlands, the journal’s aim is to foster knowledge dissemination and collaboration among professionals, researchers, and students alike, ensuring high visibility in a rapidly evolving field. The journal is committed to open access, allowing immediate access to research findings, thus maximizing their impact and facilitating advancements in clinical practice and research. With an H index that showcases its contribution to the field, Journal of Clinical and Translational Endocrinology is an essential resource for anyone invested in advancing endocrinological science.

Osteoporosis and Sarcopenia is a leading journal dedicated to the multidisciplinary exploration of diseases related to bone health and muscle degeneration, published by Elsevier. With an ISSN of 2405-5255 and an E-ISSN of 2405-5263, this open-access journal has been a vital resource since its inception in 2015, enabling unrestricted access to groundbreaking research. Its objective is to elucidate the interplay between osteoporosis and sarcopenia, offering valuable insights into diagnostics, treatment strategies, and preventive measures in the field. The journal serves as a crucial platform for researchers, healthcare professionals, and students, fostering collaboration and innovation in understanding these prevalent conditions. Given the global rise in aging populations, the significance of this journal cannot be overstated, making it an essential reference for those committed to advancing knowledge in musculoskeletal health.

Current Opinion in Endocrinology, Diabetes and Obesity, published by LIPPINCOTT WILLIAMS & WILKINS, offers a critical analysis of the latest advancements and trends in the fields of endocrinology, diabetes, and obesity. With an ISSN of 1752-296X and an E-ISSN of 1752-2978, this esteemed journal provides an authoritative platform for researchers, clinicians, and healthcare professionals to stay updated on emerging research and clinical practices. Renowned for its impactful contributions, the journal holds notable rankings, including Q2 in Endocrinology and Diabetes & Metabolism, as well as a commendable Q1 in Internal Medicine, reflecting its significance in the academic community. Although currently not an open access publication, articles published from 2007 to 2024 continually enrich the discourse on pressing health issues related to endocrinology and metabolic disorders. By fostering a comprehensive understanding of the complexities within these interconnected fields, it serves as an essential resource for any professional or student engaged in health science research.

Revista de Osteoporosis y Metabolismo Mineral, an esteemed journal published by the SOC ESPANOLA INVESTIGACION OSEA & METABOLISMO MINERAL, stands at the forefront of research in the fields of osteoporosis and mineral metabolism. Established in Spain, this Open Access journal has been providing a platform for the dissemination of innovative research and insights since 2009, ensuring accessibility for all stakeholders in the field. Although currently categorized in the Q4 quartile for Endocrinology, Diabetes and Metabolism (2023), it serves a vital role in fostering academic discourse and collaboration among researchers and healthcare professionals. With its ISSN 1889-836X and E-ISSN 2173-2345, the journal aims to contribute significantly to advancing knowledge and understanding in osteoporosis and associated metabolic disorders. The HIndex is currently not reported, highlighting the journal's emerging impact and potential for growth in the scientific community. Spanning a decade, from 2014 to 2024, the journal’s focus is an invaluable asset for students and professionals seeking to stay informed and engaged in this vital area of medicine.

The INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.

JOURNAL OF CLINICAL DENSITOMETRY, published by ELSEVIER SCIENCE INC, stands as a pivotal platform for the dissemination of cutting-edge research in the fields of endocrinology, orthopedics, and radiology. With an ISSN of 1094-6950 and an E-ISSN of 1559-0747, this journal supports the academic community with vital insights and advancements in clinical densitometry since its inception in 1998. The journal is recognized within the medical community, boasting impressive rankings such as Q3 in Endocrinology, Diabetes, and Metabolism, and Q2 in both Orthopedics and Sports Medicine and Radiology, Nuclear Medicine, and Imaging for 2023. These accolades underscore its significance as a valuable resource for researchers, healthcare professionals, and students aiming to advance their knowledge and practice in these critical areas. While it is not an Open Access publication, the journal provides vital contributions to the literature, emphasizing the importance of evidence-based approaches in clinical settings.

Osteologie is a distinguished journal published by GEORG THIEME VERLAG KG, focusing on advancing knowledge in the field of osteology and related medical disciplines. With an ISSN of 1019-1291 and E-ISSN 2567-5818, this journal plays a pivotal role in disseminating research that addresses bone health, osteoporotic conditions, and skeletal disorders. Despite its current ranking in Q4 within the broad category of Medicine (miscellaneous), and a Scopus rank placing it at the 15th percentile, Osteologie serves as a platform for emerging research and opinions in a multidisciplinary context. Curating content from 1999 to 2024, it provides valuable insights to researchers, professionals, and students keen on enhancing their understanding of bone health and its implications on overall well-being. With access options available through various academic channels, this journal remains an essential resource for those committed to the exploration and advancement of osteological science.